MannKind Corp (NASDAQ:MNKD)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

Recs

0
Player Avatar OklaBoston (68.65) Submitted: 11/12/2012 4:27:08 PM : Outperform Start Price: $1.89 MNKD Score: +72.35

Recently got a thumbs-up from one of my favorites, much insider buying lately, with improving charts.

Featured Broker Partners


Advertisement